Kevin McLain - Mar 31, 2025 Form 4 Insider Report for Ollie's Bargain Outlet Holdings, Inc. (OLLI)

Role
SVP, Merchandising
Signature
/s/ James J. Comitale as Attorney-In-Fact
Stock symbol
OLLI
Transactions as of
Mar 31, 2025
Transactions value $
-$389,437
Form type
4
Date filed
4/2/2025, 06:16 PM
Previous filing
Mar 27, 2025
Next filing
Apr 3, 2025
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction OLLI Common Stock, par value $0.001 per share Options Exercise $625K +7.82K +63.41% $79.89 20.2K Mar 31, 2025 Direct F1
transaction OLLI Common Stock, par value $0.001 per share Sale -$873K -7.82K -38.8% $111.56 12.3K Mar 31, 2025 Direct F1, F2
transaction OLLI Common Stock, par value $0.001 per share Options Exercise $413K +4.8K +38.9% $86.03 17.1K Apr 1, 2025 Direct F1
transaction OLLI Common Stock, par value $0.001 per share Sale -$555K -4.8K -28.01% $115.56 12.3K Apr 1, 2025 Direct F1, F3

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction OLLI Employee Stock Option (right to buy) Options Exercise $0 -7.82K -100% $0.00 0 Mar 31, 2025 Common Stock 7.82K $79.89 Direct F1, F4
transaction OLLI Employee Stock Option (right to buy) Options Exercise $0 -4.8K -75% $0.00 1.6K Apr 1, 2025 Common Stock 4.8K $86.03 Direct F1, F5
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Buy Plan / Sale Plan: These are also open market purchases/sales of shares, but in this case the transaction is part of a trading plan. Rule 10b5-1 allows insiders to setup a trading plan to buy/sell stocks over a certain period of time. Since the purchases/sales are predetermined, this protects the insiders from violating insider trading law.

Transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c).

Explanation of Responses:

Id Content
F1 Transactions made pursuant to an agreement adopted on December 19, 2024, in accordance with Rule 10b5-1 of the Securities Exchange Act of 1934, as amended.
F2 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $110.21-113.82, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F3 The price reported in column 4 is a weighted average price. These shares were sold in multiple transactions at prices ranging from $113.86-116.25, inclusive. The reporting person undertakes to provide to the Issuer, any securityholder of the Issuer, or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote.
F4 Options vested and became exercisable in 25% installments on each anniversary date of the grant, March 20, 2019, subject to continued service through each applicable vesting date. The options vested in their entirety on March 20, 2023.
F5 Options vested and became exercisable in 25% installments on each anniversary date of the grant, March 22, 2021, subject to continued service through each applicable vesting date. The options vested in their entirety on March 22, 2025.